Most Recent Articles about ABT
CGM Devices Gain Steam, Set New Trend in Diabetes Management http://www.zacks.com/stock/news/527773/cgm-devices-gain-steam-set-new-trend-in-diabetes-management?cid=CS-ZC-FT-analyst_blog|industry_focus-527773 Sep 20, 2019 - The FDA authorization classifies the new type of CGM devices in class II and subjects these to certain criteria called special controls.
Abbott Receives European Nod for Pediatric Heart Devices http://www.zacks.com/stock/news/524246/abbott-receives-european-nod-for-pediatric-heart-devices?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-524246 Sep 18, 2019 - Abbott (ABT) aims to offer better treatment options for the most vulnerable patient population.
Abbott Partners With Sanofi to Upgrade Diabetes Management http://www.zacks.com/stock/news/522662/abbott-partners-with-sanofi-to-upgrade-diabetes-management?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-522662 Sep 17, 2019 - Abbott (ABT) collaborates with Sanofi to revolutionize diabetes care through technological advancements.

Related Companies

Name Exchange Price Mkt Cap
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
LLY Eli Lilly and Company NYSE $105.71 $113.53B
SNY Sanofi NYSE $43.75 $109.14B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals